retatrutide ghk cu GHK-Cu 50mg Retatrutide 10mg — Triple Receptor
Description
Dosing regimens vary significantly between studies, with different titration schedules and maximum doses evaluated
This applies to Ozempic, Wegovy, Mounjaro and other GLP-1 receptor agonists currently approved for obesity or diabetes management
Serial diluted GIPR-Ab was incubated with 30,000 cells in assay buffer (0.1% BSA, 500 mM 3-isobutyl-1-methylxanthine in F12 media) for 30 min at 37 C before treatment with GIP at a final concentration of 0.05 nM
Acknowledgements Editorial assistance for this publication was provided by Christina Holleywood, PhD., and Stephen Craig, PhD
